0 Évaluations

ID

16752

Description

Boceprevir (SCH 503034) Plus Peg-Intron, With and Without Added Ribavirin, in Patients With Chronic Hepatitis C, Genotype 1, Who Did Not Respond to Previous Treatment With Peginterferon Alfa Plus Ribavirin (Study P03659AM2)(COMPLETED); ODM derived from: https://clinicaltrials.gov/show/NCT00160251

Lien

https://clinicaltrials.gov/show/NCT00160251

Mots-clés

  1. 03/08/2016 03/08/2016 -
Téléchargé le

3 août 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :


    Aucun commentaire

    Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

    Eligibility Chronic Hepatitis C NCT00160251

    Eligibility Chronic Hepatitis C NCT00160251

    Criteria
    Description

    Criteria

    documented infection with chronic hepatitis c (chc), genotype 1.
    Description

    chronic hepatitis c (chc), genotype 1

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C4049392
    documented failure to respond to an adequate course of treatment (minimum 12 weeks) with peginterferon-alfa plus ribavirin (failure defined as <2 log drop in hcv-rna after 12 weeks of therapy or those who never become hepatitis c virus ribonucleic acid (hcv)-rna negative)
    Description

    failure to respond to an adequate course of treatment with peginterferon-alfa plus ribavirin

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0162643
    UMLS CUI [1,2]
    C0919875
    UMLS CUI [1,3]
    C1875630
    no evidence of cirrhosis on liver biopsy.
    Description

    no evidence of cirrhosis on liver biopsy.

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0023890
    UMLS CUI [1,2]
    C0193388
    results of physical examination and laboratory tests within specified ranges.
    Description

    results of physical examination and laboratory tests within specified ranges

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0031809
    UMLS CUI [1,2]
    C0459422
    UMLS CUI [2,1]
    C0022885
    UMLS CUI [2,2]
    C0459422
    abstinence from use of abused substances.
    Description

    abstinence from use of abused substances

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C3843422
    UMLS CUI [1,2]
    C0687130
    key exclusion criteria:
    Description

    exclusion criteria

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0680251
    women who are pregnant or nursing a child.
    Description

    pregnant or breastfeeding

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0032961
    UMLS CUI [1,2]
    C0006147
    patients with cirrhosis, co-infection with hepatitis b or human immunodeficiency virus (hiv), and african-american patients (by protocol amendment 2, african-american patients can enroll).
    Description

    cirrhosis, co-infection with hepatitis b or human immunodeficiency virus (hiv), and african-american patients

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0023890
    UMLS CUI [2,1]
    C0275524
    UMLS CUI [2,2]
    C0019682
    UMLS CUI [3,1]
    C0275524
    UMLS CUI [3,2]
    C0019163
    UMLS CUI [4]
    C0085756
    previous treatment with any hepatitis c virus (hcv) polymerase or protease inhibitor.
    Description

    hepatitis c virus (hcv) polymerase or protease inhibitor

    Type de données

    boolean

    Alias
    UMLS CUI [1,1]
    C0019196
    UMLS CUI [1,2]
    C2746051
    UMLS CUI [2,1]
    C0019196
    UMLS CUI [2,2]
    C0033607
    patients who relapsed following response to previous treatment.
    Description

    relapse

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0277556
    evidence of advanced liver disease, or liver disease from a cause other than chc.
    Description

    advanced liver disease

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0860197
    UMLS CUI [2]
    C0009488
    pre-existing psychiatric condition.
    Description

    psychiatric condition

    Type de données

    boolean

    Alias
    UMLS CUI [1]
    C0004936

    Similar models

    Eligibility Chronic Hepatitis C NCT00160251

    Name
    Type
    Description | Question | Decode (Coded Value)
    Type de données
    Alias
    Item Group
    chronic hepatitis c (chc), genotype 1
    Item
    documented infection with chronic hepatitis c (chc), genotype 1.
    boolean
    C4049392 (UMLS CUI [1])
    failure to respond to an adequate course of treatment with peginterferon-alfa plus ribavirin
    Item
    documented failure to respond to an adequate course of treatment (minimum 12 weeks) with peginterferon-alfa plus ribavirin (failure defined as <2 log drop in hcv-rna after 12 weeks of therapy or those who never become hepatitis c virus ribonucleic acid (hcv)-rna negative)
    boolean
    C0162643 (UMLS CUI [1,1])
    C0919875 (UMLS CUI [1,2])
    C1875630 (UMLS CUI [1,3])
    no evidence of cirrhosis on liver biopsy.
    Item
    no evidence of cirrhosis on liver biopsy.
    boolean
    C0023890 (UMLS CUI [1,1])
    C0193388 (UMLS CUI [1,2])
    results of physical examination and laboratory tests within specified ranges
    Item
    results of physical examination and laboratory tests within specified ranges.
    boolean
    C0031809 (UMLS CUI [1,1])
    C0459422 (UMLS CUI [1,2])
    C0022885 (UMLS CUI [2,1])
    C0459422 (UMLS CUI [2,2])
    abstinence from use of abused substances
    Item
    abstinence from use of abused substances.
    boolean
    C3843422 (UMLS CUI [1,1])
    C0687130 (UMLS CUI [1,2])
    exclusion criteria
    Item
    key exclusion criteria:
    boolean
    C0680251 (UMLS CUI [1])
    pregnant or breastfeeding
    Item
    women who are pregnant or nursing a child.
    boolean
    C0032961 (UMLS CUI [1,1])
    C0006147 (UMLS CUI [1,2])
    cirrhosis, co-infection with hepatitis b or human immunodeficiency virus (hiv), and african-american patients
    Item
    patients with cirrhosis, co-infection with hepatitis b or human immunodeficiency virus (hiv), and african-american patients (by protocol amendment 2, african-american patients can enroll).
    boolean
    C0023890 (UMLS CUI [1])
    C0275524 (UMLS CUI [2,1])
    C0019682 (UMLS CUI [2,2])
    C0275524 (UMLS CUI [3,1])
    C0019163 (UMLS CUI [3,2])
    C0085756 (UMLS CUI [4])
    hepatitis c virus (hcv) polymerase or protease inhibitor
    Item
    previous treatment with any hepatitis c virus (hcv) polymerase or protease inhibitor.
    boolean
    C0019196 (UMLS CUI [1,1])
    C2746051 (UMLS CUI [1,2])
    C0019196 (UMLS CUI [2,1])
    C0033607 (UMLS CUI [2,2])
    relapse
    Item
    patients who relapsed following response to previous treatment.
    boolean
    C0277556 (UMLS CUI [1])
    advanced liver disease
    Item
    evidence of advanced liver disease, or liver disease from a cause other than chc.
    boolean
    C0860197 (UMLS CUI [1])
    C0009488 (UMLS CUI [2])
    psychiatric condition
    Item
    pre-existing psychiatric condition.
    boolean
    C0004936 (UMLS CUI [1])

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial